Want to see SPRY full AI Analyst Report?
ARS Pharmaceuticals (SPRY) Ownership Overview
50.06% Insiders
6.93% Mutual Funds
5.30% Other Institutional Investors
9.36% ETFs
28.35% Public Companies and
Individual Investors
The ownership structure of ARS Pharmaceuticals (SPRY) stock is a mix of institutional, retail, and individual investors. Approximately 21.59% of the company’s stock is owned by Institutional Investors, 50.06% is owned by Insiders, and 28.35% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Nov 14, 2025 | xxxxxxxxxxxxx | $189904 | |
Nov 14, 2025 | xxxxxxxxxxxxx | $1475627 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $433813 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $1046413 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,353,141 | Insider | 11.43% | 67,097,063 | |
| 11,303,141 | Insider | 11.38% | 66,801,563 | |
| 10,860,977 | Institution | 10.94% | 64,188,374 | |
| 10,860,977 | Insider | 10.94% | 64,188,374 | |
| 8,288,510 | Insider | 8.35% | 48,985,094 | |
| 7,503,812 | Institution | 7.56% | 44,347,529 | |
| 4,474,554 | Insider | 4.51% | 26,444,614 | |
| 3,062,401 | Institution | 3.08% | 18,098,790 | |
| 3,009,677 | Insider | 3.03% | 17,787,191 | |
| 2,983,823 | Institution | 3.00% | 17,634,394 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,484,080 | Institution | 2.50% | 14,680,913 | |
| 1,074,609 | Institution | 1.08% | 6,350,939 | |
| 675,416 | Institution | 0.68% | 3,991,709 | |
| 638,638 | Institution | 0.64% | 3,774,351 | |
| 351,327 | Institution | 0.35% | 2,076,343 | |
| 335,921 | Institution | 0.34% | 1,985,293 | |
| 335,156 | Institution | 0.34% | 1,980,772 | |
| 233,206 | Institution | 0.23% | 1,378,247 | |
| 168,754 | Institution | 0.17% | 997,336 | |
| 163,427 | Institution | 0.16% | 965,854 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,298,081 | Institution | 2.31% | 14,156,179 | |
| 1,749,763 | Institution | 1.76% | 14,015,602 | |
| 1,576,075 | Institution | 1.59% | 9,708,622 | |
| 745,809 | Institution | 0.75% | 5,973,930 | |
| 564,385 | Institution | 0.57% | 3,476,612 | |
| 456,899 | Institution | 0.46% | 2,814,498 | |
| 354,157 | Institution | 0.36% | 2,836,798 | |
| 308,721 | Institution | 0.31% | 1,901,721 | |
| 142,140 | Institution | 0.14% | 1,138,541 | |
| 125,318 | Institution | 0.13% | 771,959 |
FAQ
Who Owns Ars Pharmaceuticals, Inc. (SPRY)?
According to the latest TipRanks data, approximately 5.30% of the company's stock is held by institutional investors, 50.06% is held by insiders, and 28.35% is held by retail investors.
What percentage of Ars Pharmaceuticals, Inc. (SPRY) stock is held by institutional investors?
According to the latest TipRanks data, approximately 5.30% of Ars Pharmaceuticals, Inc. (SPRY) stock is held by institutional investors.
What percentage of Ars Pharmaceuticals, Inc. (SPRY) stock is held by retail investors?
According to the latest TipRanks data, approximately 28.35% of Ars Pharmaceuticals, Inc. (SPRY) stock is held by retail investors.
Who owns the most shares of Ars Pharmaceuticals, Inc. (SPRY)?
Sarina Tanimoto owns the most shares of Ars Pharmaceuticals, Inc. (SPRY).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.